Discontinued Cardiovascular and Metabolic Drug Database

The database records the following features of discontinued drugs for cardiovascular and metabolic diseases within the 2011-2021 time-window: ● drug name ● sponsor company ● genetic target (N/A for those that are unclear or involves analog/replacement) ● target name (usually a protein) and acronyms ● indications ● highest stage when the drug was discontinued ● year of discontinuation ● reason for discontinuation (if there is any) ● source of information ● new indications, new name, the highest stage of repurposing and the company that repurposed the drug.

本数据库记录了2011至2021年时间窗内，心血管及代谢疾病领域已终止研发药物的以下各项特征：
● 药物名称
● 申办方公司
● 遗传靶点（若靶点不明确或涉及类似物/替代物，则标注为N/A）
● 靶点名称（通常为蛋白质）及其缩写
● 适应症
● 该药物终止研发时所处的最高研发阶段
● 终止研发年份
● 终止研发原因（如有）
● 信息来源
● 新适应症、新名称、该药物再利用的最高阶段以及开展该药物再利用的公司。